These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12916270)

  • 1. [Influence of hormone replacement therapy (oral and transdermal) on activity of erythrocyte Zn/Cu superoxide dismutase (Zn/Cu-SOD) in postmenopausal women].
    Radowicki S; Jankowska S; Kunicki M
    Ginekol Pol; 2003 Apr; 74(4):282-7. PubMed ID: 12916270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trace mineral status in post menopausal women: impact of hormonal replacement therapy.
    Bureau I; Anderson RA; Arnaud J; Raysiguier Y; Favier AE; Roussel AM
    J Trace Elem Med Biol; 2002; 16(1):9-13. PubMed ID: 11878754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of oestradiol and oestroprogestin on erythrocyte antioxidative enzyme system activity in postmenopausal women.
    Bednarek-Tupikowska G; Tworowska U; Jedrychowska I; Radomska B; Tupikowski K; Bidzinska-Speichert B; Milewicz A
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):463-8. PubMed ID: 16584521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of activity, but no decrease in concentration, of erythrocyte Cu,Zn-superoxide dismutase by hyperglycaemia in diabetic patients.
    Kotake M; Shinohara R; Kato K; Hayakawa N; Hayashi R; Uchimura K; Makino M; Nagata M; Kakizawa H; Nakagawa H; Nagasaka A; Itoh M
    Diabet Med; 1998 Aug; 15(8):668-71. PubMed ID: 9702470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women.
    Ichikawa J; Sumino H; Ichikawa S; Ozaki M
    Am J Hypertens; 2006 Jul; 19(7):744-9. PubMed ID: 16814131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen plus progestin increase superoxide dismutase and total antioxidant capacity in postmenopausal women.
    Unfer TC; Figueiredo CG; Zanchi MM; Maurer LH; Kemerich DM; Duarte MM; Konopka CK; Emanuelli T
    Climacteric; 2015 Jun; 18(3):379-88. PubMed ID: 25236970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Participation of metallothionein and superoxide dismutase in the blood of smoking smelters.
    Bizoń A; Milnerowicz H
    Int J Occup Med Environ Health; 2014 Apr; 27(2):326-34. PubMed ID: 24692073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone replacement therapy and breast density changes.
    Harvey J; Scheurer C; Kawakami FT; Quebe-Fehling E; de Palacios PI; Ragavan VV
    Climacteric; 2005 Jun; 8(2):185-92. PubMed ID: 16096175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of inflammation and copper intake on rat liver and erythrocyte Cu-Zn superoxide dismutase activity levels.
    DiSilvestro RA; Marten JT
    J Nutr; 1990 Oct; 120(10):1223-7. PubMed ID: 2213250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiponectin and endothelial markers in postmenopausal women taking oral or transdermal hormone therapy.
    Ruszkowska B; Sokup A; Kulwas A; Kwapisz J; Góralczyk K; Socha MW; Rhone P; Rość D
    Acta Obstet Gynecol Scand; 2013 Jul; 92(7):841-6. PubMed ID: 23472599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuation of postmenopausal hormone replacement therapy in a large health maintenance organization: transdermal matrix patch versus oral estrogen therapy.
    Ettinger B; Pressman A
    Am J Manag Care; 1999 Jun; 5(6):779-85. PubMed ID: 10538456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of oral and transdermal hormone replacement therapy on plasma homocysteine levels.
    Chiantera V; Sarti CD; Fornaro F; Farzati A; De Franciscis P; Sepe E; Borrelli AL; Colacurci N
    Menopause; 2003; 10(4):286-91. PubMed ID: 12851511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of continuation of postmenopausal hormone replacement therapy: transdermal versus oral estrogen.
    Ettinger B; Pressman A; Bradley C
    Menopause; 1998; 5(3):152-6. PubMed ID: 9774760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The benefits of hormone replacement therapy on plasma and platelet antioxidant status and fatty acid composition in healthy postmenopausal women.
    Gokkusu C; Tata G; Ademoğlu E; Tamer S
    Platelets; 2010; 21(6):439-44. PubMed ID: 20459351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of effects of sequential transdermal administration versus oral administration of estradiol plus norethisterone acetate on serum NO levels in postmenopausal women.
    Kurtay G; Ozmen B; Erguder I
    Maturitas; 2006 Jan; 53(1):32-8. PubMed ID: 16325022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copper and zinc concentrations and the activities of ceruloplasmin and superoxide dismutase in atherosclerosis obliterans.
    Iskra M; Majewski W
    Biol Trace Elem Res; 2000 Jan; 73(1):55-65. PubMed ID: 10949969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of transdermal and oral hormone replacement therapies on monocyte chemoattractant protein-1 levels: a randomized clinical trial.
    Taşçı T; Şükür YE; Özmen B; Atabekoğlu CS; Cengiz SD; Koçbulut E; Berker B; Sönmezer M
    Eur J Obstet Gynecol Reprod Biol; 2014 May; 176():50-4. PubMed ID: 24655552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of oral conjugated equine estrogen and transdermal estrogen on atherosclerotic vascular disease risk markers and endothelial function in healthy postmenopausal women.
    Ho JY; Chen MJ; Sheu WH; Yi YC; Tsai AC; Guu HF; Ho ES
    Hum Reprod; 2006 Oct; 21(10):2715-20. PubMed ID: 16807281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trace element and magnesium levels and superoxide dismutase activity in rheumatoid arthritis.
    Tuncer S; Kamanli A; Akçil E; Kavas GO; Seçkin B; Atay MB
    Biol Trace Elem Res; 1999 May; 68(2):137-42. PubMed ID: 10327024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone replacement therapy: relation to homocysteine and prooxidant-antioxidant status in healthy postmenopausal women.
    Gökkuşu C; Özbek Z; Tata G
    Arch Gynecol Obstet; 2012 Mar; 285(3):733-9. PubMed ID: 21877144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.